Transfusion-attributable acute respiratory distress syndrome, hospital utilization and costs in the USA: A model simulation

Transfusion Alternatives in Transfusion Medicine

Volumn 10, Issue 1, 2008, Pages 1-8

  Zilberberg, Marya D ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

ARDS; Economics; Transfusion

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CAUSAL ATTRIBUTION; CONTROLLED STUDY; ECONOMIC EVALUATION; ERYTHROCYTE CONCENTRATE; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL UTILIZATION; LENGTH OF STAY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MONTE CARLO METHOD; PRIORITY JOURNAL; UNITED STATES;

EID: 65249154181     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2007.00087.x     Document Type: Article

References (43)

1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-93.
2. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest 2006; 130: 869-78.
3. Hopkins RO, Weaver LK, Collingridge D, et al. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171: 340-7.
4. Chelluri L, Im KA, Belle SH, et al. Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med 2004; 32: 61-69.
5. Angus DC, Clermont G, Linde-Zwirble WT, et al. Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med 2006; 34: 2883-90.
6. Catlin HA, Cowan C, Heffler S, et al. National health spending in 2005: the slowdown continues. Health Affairs 2007; 26: 142-53.
7. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion related acute lung injury. Transfusion 1985; 25: 573-77.
8. Silliman CC, Boshkov LK, Mehdizzadehkashi Z, et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.
9. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005; 33: 721-6.
10. Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion. Crit Care Med 2005; 33: 1191-8.
11. Kahn JM, Caldwell EC, Deem S, et al. Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors, and outcome. Crit Care Med 2006; 34: 196-202.
12. Zilberberg MD, Carter C, Lefebvre P, et al. Red blood cell transfusions and the risk of ARDS among critically ill: A cohort study. Crit Care 2007; 11: R63.
13. Hebert PC, Wells G, Blajchman MA, et al. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-17.
14. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: Anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
15. Vincent JL, Baron JF, Reinhart K, et al. ABC (anemia and blood transfusion in critical care) investigators: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507.
16. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288: 2827-35.
17. Levy MM, Abraham E, Zilberberg M, et al. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. Chest 2005; 127: 928-35.
18. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005; 33: 1266-71.
19. Halpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985-2000: An analysis of bed numbers, use, and costs. Crit Care Med 2004; 32: 1254-9.
20. HCUPnet. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD, 2004. Accessed at http://www.ahrq.gov/HCUPnet/ (accessed 13 December 2006).
21. Centers for Medicare and Medicaid Services. 2004 PPS Impact File and Payment Record Layout, 2004. Accessed at http://www.cms.hhs.gov/ AcuteInpatientPPS/ (accessed 30 November 2006).
22. Rana R, Afessa B, Keegan MT, et al. Evidence-based red cell transfusion in the critically ill: Quality improvement using computerized physician order entry. Crit Care Med 2006; 34: 1892-7.
23. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA 2002; 287: 1968-71.
24. Kopko PM, Pagliaroni TG, Popovsky MA, et al. TRALI: Correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003; 43: 177-84.
25. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion 1997; 37: 719-26.
26. Kristiansson M, Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: Promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996; 40: 496-501.
27. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction?. Blood 2001; 7: 180-95.
28. Lee TH, Stromberg RR, Heitman J, et al. Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. Transfusion 1994; 34: 986-94.
29. Fransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-9.
30. Klein HG. Immunomodulatory aspects of transfusion: A once and future risk? Anesthesiology 1999; 91: 861-5.
31. Silverboard H, Aisiku I, Martin GS, et al. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma 2005; 59: 717-23.
32. Shorr AF, Jackson WL, Kelly KM, et al. Transfusion practice and blood stream infections in critically ill patients. Chest 2005; 127: 1722-8.
33. Shorr AF, Duh MS, Kelly KM, et al. Red blood cell transfusion and ventilator-associated pneumonia: A potential link?. Crit Care Med 2004; 32: 666-74.
34. Earley AS, Gracias VH, Haut E, et al. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. J Trauma 2006; 61: 1-7.
35. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-21.
36. Resar R, Pronovost P, Haraden C, et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31: 243-8.
37. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725-32.
38. Yilmaz M, Keegan MT, Iscimen R, et al. Toward the prevention of acute lung injury: Protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007; 35: 1660-6.
39. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
40. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003; 31: 1607-11.
41. National Heart and Lung Institute. Task force on problems, research approaches, needs: The lung program. Washington, DC. Department of Health, Education and Welfare, 1972 (Publication no. (NIH) 73-432.)
42. Watkins TR, Rubenfeld GD, Martin TR, etal. Effects of leukoreduced blood transfusion on acute lung injury in trauma patients: A randomized controlled trial [abstract]. Proc Am Thoracic Soc 2006; 3: A301.
43. Nathens AB, Nester TA, Rubenfeld GD, et al. The effects of leukoreduced blood transfusion on infection risk following injury: A randomized controlled trial. Shock 2006; 26: 342-7.